The Sepsis Diagnostics Market trends point towards significant growth, with the market expected to reach USD 890 million by 2029, up from USD 634 million in 2024, at a 7.0% CAGR. Key factors driving this growth include the proliferation of diagnostic centers and hospitals, along with increasing public-private research funding. The rising use of biomarker profiling in sepsis diagnostics is also anticipated to contribute to the market’s expansion.
Based on the product, sepsis diagnostics is segmented into blood culture media, assays & reagents, instruments, and software. During the forecast period, blood culture media is expected to dominate the sepsis diagnostics market. The growth of the media segment will be driven by being the standard method across the globe for sepsis diagnostics.
Based on method, sepsis diagnostics is segmented into conventional diagnostics and automated diagnostics. During the forecast period,automated diagnostics is expected to dominate the sepsis diagnostics market. Automated diagnosticsreduces risk of contamination, provides quick turnaround time and accurate detection of positive blood cultures which is anticipated to further propel market growth.
Based on test type, the sepsis diagnostics market is segmented into laboratory tests and point-of-care tests. During the forecast period, the laboratory tests segment is estimated to hold the largest market share during the forecast period. While the point-of-care tests segment is expected to grow at the highest CAGR. The rising adoption of POC testing devices and increasing technological advancements is the major driver for growth.
Based on end user, the sepsis diagnostics market is segmented into hospitals & specialty clinics, pathology & reference labs and research laboratories, academic institutes & CROs. During the forecast period,hospitals & specialty clinics is expected to account for the largest market share in the sepsis diagnostics market. The large share of this segment is attributed to the the increasing number of initiatives taken by hospitals to identify and diagnose sepsis and furthermore high prevalence of sepsis among ICU patients.
The sepsis diagnostics market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East. The market in the Asia Pacific region is expected to offer significant opportunities for the growth of the sepsis diagnostics market in 2024. The growth of the market can be attributed to the presence of a large target patient population, improving diagnosis and treatment rates for sepsis, and growing adoption of advanced diagnostics options in several Asia Pacific countries.
Sources:
https://www.marketsandmarkets.com/PressReleases/sepsis-diagnostic.asp
https://finance.yahoo.com/news/sepsis-diagnostics-market-expected-reach-123000491.html
Mar 12, 2020: The global Prosthetics and Orthotics market size is expected to reach USD 13.3 billion by 2027, according to a new report by Radiant Insights, Inc., registering a 4.6% CAGR over the forecast period.
Increasing incidences of sports injuries, rising incidence of osteosarcoma, and expanding geriatric population base are key factors driving the market.Rising geriatric population across the globe has become a major factor driving demand for prosthetics and orthotics.
For instance, as per the United Nations, the number of people aged 60 years or over globally is expected to more than double by 2050, increasing from 962 million in 2017 to 2.1 billion in 2050.
The elderly are more susceptible to conditions such as osteoporosis and osteopenia, making them common users of various orthopedic solutions.To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/prosthetics-and-orthotics-market/request-sampleIncreasing incidence of osteosarcoma in young adults and children is also driving the market to a great extent.
Around 800 to 900 new cases of osteosarcoma are reported in the U.S. each year as of 2018.Further key findings from the report suggest:In terms of revenue, the orthotics segment is projected to expand at a CAGR of 4.0% over the forecast period.
Increasing cases of diabetes-related amputations across the globe are acting as the driving factor for this segmentBy revenue, Asia Pacific is expected to exhibit the highest growth rate over the forecast period.
